Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
90 participants
OBSERVATIONAL
2020-02-24
2022-02-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* While neurobiological specificity of each BD subtype is still controversial, available evidence suggest different dopaminergic abnormalities in each subtype. Dopaminergic function is involved in decision making and reward processing which may represent useful BD subtype markers.
* This study aims at assessing decision making during appetitive and punitive reinforcement learning in patients with BD I and BD II subtypes compared to healthy controls
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identification of Predictive Biomarkers of Mood Relapses in Patients With Bipolar Disorder
NCT04703972
Self-compassion and Bipolar Disorder
NCT06497868
Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults With Bipolar Disorder
NCT03829787
Facial Emotion Recognition in Patients With Euthymic Bipolar Disorder I and II
NCT05922956
Effects of Psycho-education of Patients With Bipolar Disorder
NCT00159562
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bipolar disorder type I
behavioral assessment
Probabilistic learning task
Bipolar disorder type II
behavioral assessment
Probabilistic learning task
healthy controls
behavioral assessment
Probabilistic learning task
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
behavioral assessment
Probabilistic learning task
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Montgomery and Asberg Depression Rating Scale (MADRS) score \< 15
* Young Mania Rating Scale (YMRS) score \< 12
Exclusion Criteria
* other medical condition leading to cognitive deterioration
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Grenoble Alpes
Grenoble, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A01962-53
Identifier Type: OTHER
Identifier Source: secondary_id
38RC18.171
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.